Cover Image

Eczematous reactions to psoriasis biologics treated with dupilumab: A case series

Saved in:

Bibliographic Details
Main Authors:	Merav Koschitzky, BA (Author), Kathryn Tan, MD (Author), Maria Rosa Noliza Encarnacion, MD (Author), Ryan Rivera-Oyola, MS (Author), Saakshi Khattri, MD (Author)
Format:	Book
Published:	Elsevier, 2021-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Apremilast as a treatment for morphea: A case series
by: Merav Koschitzky, BA, et al.
Published: (2022)

Eczematous liraglutide eruption managed by dupilumab: A case report
by: Claudia Paganini, MD, et al.
Published: (2024)

Intravenous immunoglobulin-induced eczematous dermatitis treated with dupilumab
by: Katelyn Singh, MD, et al.
Published: (2024)

Severe cutaneous reaction with initiation of dupilumab for atopic dermatitis and prurigo nodularis: An unusual adverse effect
by: Leore Lavin, MSc, et al.
Published: (2024)

A novel application of dupilumab in treatment-resistant follicular mucinosis
by: Saud Binsufayan, MD, et al.
Published: (2023)

Refractory eczematous dermatitis arising after allogeneic hematopoietic stem cell transplantation responsive to dupilumab
by: Jenny Lai, PhD, et al.
Published: (2024)

Eczematous reaction to IVIG for the treatment of dermatomyositis
by: J. Berk-Krauss, et al.
Published: (2018)

Pravastatin-Induced Eczematous Eruption Mimicking Psoriasis
by: Michael P. Salna, et al.
Published: (2017)

Dermatologic findings in 2 patients with COVID-19
by: Ryan Rivera-Oyola, MS, et al.
Published: (2020)

Dupilumab-induced phenotype switching from atopic dermatitis to psoriasis
by: Aakaash Varma, BA, et al.
Published: (2020)

Ulcerative injection-site reaction associated with dupilumab therapy
by: Michael Phan, BS, et al.
Published: (2020)

Six cases of refractory pruritus and histologic dermal hypersensitivity reaction successfully treated with dupilumab
by: Nicole Edmonds, BA, et al.
Published: (2022)

A clinician's guide to cutaneous T-cell lymphoma presenting as recalcitrant eczematous dermatitis in adults
by: Sarah Semaan, BS, et al.
Published: (2021)

Lichenoid-granulomatous drug reactions to dupilumab: A report of 2 cases
by: Zahra Rehan, BSc, et al.
Published: (2023)

An eczematous eruption on the arm
by: Kazunari Sugita, et al.
Published: (2021)

Dupilumab as a novel therapy for management of delusions of parasitosis: A case series
by: Nupur Singh, BA, et al.
Published: (2024)

Progressing eczematous dermatitis in an infantile hemangioma with minimal or arrested growth treated with tacrolimus ointment
by: Raya Qais Alsaid, MD, et al.
Published: (2020)

Dupilumab in HIV-positive patients: A case series report of 4 patients
by: Ameen Alawadhi, MD, et al.
Published: (2020)

The use of dupilumab for the treatment of recalcitrant brachioradial pruritus
by: Mary Kathryn Abel, AB, et al.
Published: (2021)

Persistent eczematous lesions over the body
by: Ramesh M Bhat, et al.
Published: (2014)

Eczematous skin lesion with nipple destruction
by: Arun C Inamadar
Published: (2012)

Recalcitrant palmoplantar pustulosis controlled with dupilumab
by: Hannah D. Smith, BA, et al.
Published: (2023)

Pemphigoid gestationis treated with dupilumab
by: Rita E. Chen, BA, et al.
Published: (2023)

Prolonged hypereosinophilia associated with dupilumab for atopic dermatitis: A case series and review of literature
by: Gabriela Fonseca, BS, et al.
Published: (2024)

Dupilumab for the treatment of pityriasis lichenoides chronica
by: Charissa N. Obeng-Nyarko, MS, et al.
Published: (2024)

A retrospective multicenter case series of real-world tralokinumab use in dupilumab-experienced patients
by: Edward I. Herman, MD, PhD, et al.
Published: (2024)

Dupilumab as treatment of actinic prurigo suggests pathophysiologic mechanism of disease: A case series
by: Catherine S. Barker, MD, et al.
Published: (2024)

Injection site reactions due to the use of biologics in patients with psoriasis: A retrospective study
by: Yun Kyung Jang, MD, et al.
Published: (2023)

Efficacy of topical Doxepin in the treatment of eczematous dermatoses
by: Samaresh Chandra Hazra, et al.
Published: (2013)

Two cases of eczematous eruptions caused by everolimus
by: Minako Habu, et al.
Published: (2019)

Review of dupilumab-associated inflammatory arthritis: An approach to clinical analysis and management
by: Ryan Jay, BA, BS, et al.
Published: (2022)

Treatment of prolonged drug reaction with eosinophilia and systemic symptoms syndrome with dupilumab using a molecularly-guided approach
by: Kailyn Valido, BS, et al.
Published: (2024)

Dupilumab: One therapy to treat multiple atopic diseases
by: Fatima Bawany, BA, et al.
Published: (2020)

Successful use of dupilumab in recalcitrant pediatric atopic dermatitis-like graft-versus-host disease: A case series
by: Lina Belmesk, MD, et al.
Published: (2024)

Vitiligo during dupilumab therapy
by: Vincenzo Picone, MD, et al.
Published: (2023)

JAK-inhibitors as rescue therapy in dupilumab-refractory severe atopic dermatitis: A case series of 6 patients
by: Neda Shahriari, MD, et al.
Published: (2023)

Use of a topical Janus kinase inhibitor in immune checkpoint inhibitor-induced eczematous reaction: a case report
by: Camille M. Powers, et al.
Published: (2024)

Spesolimab use in treatment of pyoderma gangrenosum
by: Sophie H. Guénin, MSc, et al.
Published: (2023)

Novel use of dupilumab in pemphigus vulgaris and pemphigus foliaceus
by: Christina Jiang, BS, MS, et al.
Published: (2023)

Dupilumab-induced pityriasis rosea
by: Morgan Zabel, BS, et al.
Published: (2023)